Although xCT has a restricted expression pattern, limited to the brain, immune system and eyes, under physiological conditions [8], in cancer cells derived from most tumor types, the transporter is abundantly expressed at the cell membrane, where it promotes cell survival under oxidative stress conditions [8]. This evidence concerns the gene SLC7A11 and neoplasm.